• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘草酸体外抑制EB病毒复制的作用机制

Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro.

作者信息

Lin Jung Chung

机构信息

Department of Microbiology, College of Medicine, Tzu Chi University, 701 Section 3, Chung Yang Road, Hualien 970, Taiwan ROC.

出版信息

Antiviral Res. 2003 Jun;59(1):41-7. doi: 10.1016/s0166-3542(03)00030-5.

DOI:10.1016/s0166-3542(03)00030-5
PMID:12834859
Abstract

We report here that glycyrrhizic acid (GL), a component of licorice root (Glycyrrhiza radix), is active against EBV replication in superinfected Raji cells in a dose-dependent fashion. The IC(50) values for viral inhibition and cell growth were 0.04 and 4.8mM, respectively. The selectivity index (ratio of IC(50) for cell growth to IC(50) for viral DNA synthesis) was 120. Time of addition experiments suggested that GL interferes with an early step of EBV replication cycle (possibly penetration). GL had no effect on viral adsorption, nor did it inactivate EBV particles. Thus, GL represents a new class of anti-EBV compounds with a mode of action different from that of the nucleoside analogs that inhibit viral DNA polymerase.

摘要

我们在此报告,甘草根(Glycyrrhiza radix)的成分甘草酸(GL)对超感染的Raji细胞中的EBV复制具有剂量依赖性的活性。病毒抑制和细胞生长的IC50值分别为0.04和4.8mM。选择性指数(细胞生长的IC50与病毒DNA合成的IC50之比)为120。添加时间实验表明,GL干扰EBV复制周期的早期步骤(可能是穿透)。GL对病毒吸附没有影响,也不会使EBV颗粒失活。因此,GL代表了一类新型的抗EBV化合物,其作用方式不同于抑制病毒DNA聚合酶的核苷类似物。

相似文献

1
Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro.甘草酸体外抑制EB病毒复制的作用机制
Antiviral Res. 2003 Jun;59(1):41-7. doi: 10.1016/s0166-3542(03)00030-5.
2
Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.甘草酸某些衍生物对爱泼斯坦-巴尔病毒感染的抑制作用:构效关系
Antiviral Res. 2008 Jul;79(1):6-11. doi: 10.1016/j.antiviral.2008.01.160. Epub 2008 Mar 31.
3
Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.爱泼斯坦-巴尔病毒的感染机制。I. 超感染的拉吉细胞中病毒DNA复制及非感染性病毒颗粒的形成
J Virol. 1976 Jul;19(1):187-94. doi: 10.1128/JVI.19.1.187-194.1976.
4
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication.新型无环腺苷类似物可抑制爱泼斯坦-巴尔病毒复制。
Antimicrob Agents Chemother. 1987 Sep;31(9):1431-3. doi: 10.1128/AAC.31.9.1431.
5
Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.9-(1,3-二羟基-2-丙氧甲基)鸟嘌呤对爱泼斯坦-巴尔病毒复制的持久抑制作用
J Virol. 1984 Apr;50(1):50-5. doi: 10.1128/JVI.50.1.50-55.1984.
6
Screening of drugs inhibiting Epstein-Barr virus replication.抑制爱泼斯坦-巴尔病毒复制的药物筛选。
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1996 May;29(2):80-9.
7
Inhibitory effect of 1-beta-D-arabinofuranosylthymine on synthesis of Epstein-Barr virus.1-β-D-阿拉伯呋喃糖基胸腺嘧啶对爱泼斯坦-巴尔病毒合成的抑制作用。
Microbiol Immunol. 1981;25(6):557-63. doi: 10.1111/j.1348-0421.1981.tb00057.x.
8
Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.膦甲酸对爱泼斯坦-巴尔病毒DNA合成及晚期基因表达的抑制作用
J Virol. 1976 Apr;18(1):151-5. doi: 10.1128/JVI.18.1.151-155.1976.
9
Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.螺内酯通过抑制EBV SM蛋白功能来阻断爱泼斯坦-巴尔病毒的产生。
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3609-14. doi: 10.1073/pnas.1523686113. Epub 2016 Mar 14.
10
Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.用于评估抗病毒药物对爱泼斯坦-巴尔病毒复制及EBV晚期mRNA表达影响的实时定量PCR
J Virol Methods. 2007 Jul;143(1):38-44. doi: 10.1016/j.jviromet.2007.02.005. Epub 2007 Mar 19.

引用本文的文献

1
Anti-dengue viral activity of Glycyrrhiza glabra roots in Vero cells.甘草根在 Vero 细胞中的抗登革热病毒活性。
Sci Rep. 2024 Oct 29;14(1):25922. doi: 10.1038/s41598-024-76184-5.
2
Baicalin Inhibits FIPV Infection In Vitro by Modulating the PI3K-AKT Pathway and Apoptosis Pathway.黄芩苷通过调节 PI3K-AKT 通路和细胞凋亡通路抑制 FIPV 感染。
Int J Mol Sci. 2024 Sep 14;25(18):9930. doi: 10.3390/ijms25189930.
3
Update of Natural Products and Their Derivatives Targeting Epstein-Barr Infection.针对 Epstein-Barr 感染的天然产物及其衍生物的更新。
Viruses. 2024 Jan 15;16(1):124. doi: 10.3390/v16010124.
4
The Dual Functions of Andrographolide in the Epstein-Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein-Barr Virus and the Induction of Cell Death.穿心莲内酯在 EBV 阳性头颈部癌细胞中的双重作用:抑制 EBV 溶活性再激活和诱导细胞死亡。
Int J Mol Sci. 2023 Nov 1;24(21):15867. doi: 10.3390/ijms242115867.
5
Antiviral Activity of Natural Herbs and their Isolated BioactiveCompounds: A Review.天然草药及其分离生物活性化合物的抗病毒活性:综述。
Comb Chem High Throughput Screen. 2024;27(14):2013-2042. doi: 10.2174/0113862073267048231027070537.
6
A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide.甘草酸、甘草次酸和甘草次酸单葡萄糖醛酸苷的抗病毒活性综述
Pharmaceuticals (Basel). 2023 Apr 23;16(5):641. doi: 10.3390/ph16050641.
7
The Interaction of the Transmembrane Domain of SARS-CoV-2 E-Protein with Glycyrrhizic Acid in Lipid Bilayer.严重急性呼吸综合征冠状病毒2型E蛋白跨膜结构域与甘草酸在脂质双层中的相互作用
Membranes (Basel). 2023 May 10;13(5):505. doi: 10.3390/membranes13050505.
8
Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences.甘草甜素作为对抗新型冠状病毒的一种有前景的克星:临床、实验及理论证据
J Mol Struct. 2023 Mar 5;1275:134642. doi: 10.1016/j.molstruc.2022.134642. Epub 2022 Nov 25.
9
Analysis of the network pharmacology and the structure-activity relationship of glycyrrhizic acid and glycyrrhetinic acid.甘草酸和甘草次酸的网络药理学及构效关系分析
Front Pharmacol. 2022 Oct 13;13:1001018. doi: 10.3389/fphar.2022.1001018. eCollection 2022.
10
Recent Advances in Antiviral Activities of Triterpenoids.三萜类化合物抗病毒活性的最新进展
Pharmaceuticals (Basel). 2022 Sep 21;15(10):1169. doi: 10.3390/ph15101169.